US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.000
  • +2.270+2.50%
Close Apr 26 16:00 ET
  • 94.990
  • +1.990+2.14%
Post 19:13 ET
5.84BMarket Cap-11111P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-24.80%710.64M
-24.80%710.64M
-37.29%712.98M
-15.29%722.63M
40.10%822.16M
98.06%944.99M
98.06%944.99M
61.99%1.14B
35.77%853.11M
-31.12%586.83M
-Cash and cash equivalents
-40.45%71.29M
-40.45%71.29M
-80.79%55.97M
-56.44%75.53M
356.26%169.72M
-42.98%119.71M
-42.98%119.71M
-47.36%291.43M
-67.55%173.4M
-94.67%37.2M
-Short-term investments
-22.53%639.36M
-22.53%639.36M
-22.30%657.01M
-4.80%647.11M
18.71%652.44M
208.90%825.28M
208.90%825.28M
470.21%845.54M
622.85%679.71M
256.91%549.63M
Receivables
16.89%43.18M
16.89%43.18M
88.25%41.25M
30.12%38.27M
-3.97%31.3M
-0.25%36.94M
-0.25%36.94M
-26.27%21.92M
-25.05%29.41M
-25.68%32.6M
-Accounts receivable
82.05%42.83M
82.05%42.83M
111.50%40.86M
29.58%35.15M
4.34%30.01M
-6.48%23.53M
-6.48%23.53M
5.00%19.32M
6.48%27.12M
-17.03%28.76M
-Other receivables
-97.38%351K
-97.38%351K
-84.86%393K
36.42%3.12M
-66.25%1.3M
12.95%13.41M
12.95%13.41M
-77.08%2.6M
-83.39%2.29M
-58.27%3.84M
Inventory
-28.53%21.22M
-28.53%21.22M
-53.32%16.46M
-52.01%17.02M
-41.88%17.52M
36.12%29.7M
36.12%29.7M
112.75%35.25M
133.08%35.45M
88.05%30.15M
Prepaid assets
----
----
----
----
----
----
----
41.63%33.53M
60.81%34.2M
45.71%37.68M
Other current assets
-4.78%33.35M
-4.78%33.35M
--37.48M
--33.42M
--29.36M
93.89%35.02M
93.89%35.02M
----
----
----
Total current assets
-22.76%808.39M
-22.76%808.39M
-34.17%808.17M
-14.79%811.34M
31.01%900.34M
88.92%1.05B
88.92%1.05B
59.06%1.23B
35.24%952.18M
-26.71%687.24M
Non current assets
Net PPE
0.39%115.65M
0.39%115.65M
-1.30%115.84M
-3.81%114.49M
-4.88%113.41M
-4.69%115.2M
-4.69%115.2M
24.61%117.37M
23.60%119.02M
20.46%119.23M
-Gross PPE
5.23%154.14M
5.23%154.14M
-1.30%115.84M
-3.81%114.49M
-4.88%113.41M
0.14%146.48M
0.14%146.48M
24.61%117.37M
-0.14%119.02M
-0.87%119.23M
-Accumulated depreciation
-23.05%-38.49M
-23.05%-38.49M
----
----
----
-23.07%-31.28M
-23.07%-31.28M
----
----
----
Investments and advances
-47.72%84.32M
-47.72%84.32M
70.17%142.03M
50.69%141.72M
-45.54%166.94M
-71.07%161.27M
-71.07%161.27M
-85.90%83.46M
-87.49%94.05M
-46.98%306.53M
Other non current assets
52.66%40.89M
52.66%40.89M
31.33%39.26M
43.03%38.9M
30.91%39.68M
35.21%26.78M
35.21%26.78M
54.37%29.89M
62.59%27.2M
187.81%30.31M
Total non current assets
-20.58%240.86M
-20.58%240.86M
28.78%297.13M
22.83%295.11M
-29.83%320.03M
-56.57%303.25M
-56.57%303.25M
-67.29%230.73M
-72.21%240.27M
-33.68%456.06M
Total assets
-22.27%1.05B
-22.27%1.05B
-24.21%1.11B
-7.21%1.11B
6.74%1.22B
7.80%1.35B
7.80%1.35B
-1.28%1.46B
-23.99%1.19B
-29.66%1.14B
Liabilities
Current liabilities
Payables
72.59%4.71M
72.59%4.71M
64.49%6.96M
-53.64%6.98M
-41.19%10.56M
-67.25%2.73M
-67.25%2.73M
-55.67%4.23M
715.00%15.05M
521.70%17.96M
-accounts payable
72.59%4.71M
72.59%4.71M
64.49%6.96M
-53.64%6.98M
-41.19%10.56M
-67.25%2.73M
-67.25%2.73M
-55.67%4.23M
715.00%15.05M
521.70%17.96M
Current accrued expenses
-26.54%67.09M
-26.54%67.09M
-32.68%59.82M
-34.07%61.43M
-2.81%79.69M
2.93%91.33M
2.93%91.33M
28.27%88.86M
5.47%93.17M
11.55%81.99M
Current provisions
93.07%17.47M
93.07%17.47M
152.37%16.1M
120.37%13.56M
136.22%12.03M
130.41%9.05M
130.41%9.05M
117.08%6.38M
184.37%6.15M
208.91%5.09M
Current debt and capital lease obligation
53.89%42.21M
53.89%42.21M
64.68%41.84M
208.95%29.15M
222.63%28.27M
238.93%27.43M
238.93%27.43M
188.38%25.41M
11.46%9.44M
6.94%8.76M
-Current debt
79.68%30.28M
79.68%30.28M
97.65%30.22M
--17.86M
--17.38M
--16.85M
--16.85M
--15.29M
----
----
-Current capital lease obligation
12.80%11.93M
12.80%11.93M
14.84%11.62M
19.68%11.29M
24.25%10.89M
30.72%10.58M
30.72%10.58M
14.82%10.12M
11.46%9.44M
6.94%8.76M
Current deferred liabilities
82.26%40.01M
82.26%40.01M
51.93%38.15M
111.73%31.74M
161.53%25.12M
90.72%21.95M
90.72%21.95M
269.67%25.11M
89.46%14.99M
-35.44%9.6M
Current liabilities
17.29%214.92M
17.29%214.92M
12.46%197.38M
6.47%169.03M
26.02%172.68M
22.35%183.23M
22.35%183.23M
46.64%175.51M
26.61%158.76M
21.87%137.03M
Non current liabilities
Long term debt and capital lease obligation
35.00%290.29M
35.00%290.29M
33.69%292.19M
113.12%209.2M
110.47%212.07M
108.12%215.02M
108.12%215.02M
191.20%218.56M
27.03%98.16M
26.78%100.76M
-Long term debt
70.61%208.54M
70.61%208.54M
69.15%208.16M
--122.15M
--122.13M
--122.23M
--122.23M
--123.06M
----
----
-Long term capital lease obligation
-11.90%81.75M
-11.90%81.75M
-12.00%84.04M
-11.32%87.05M
-10.74%89.94M
-10.19%92.79M
-10.19%92.79M
27.24%95.5M
27.03%98.16M
26.78%100.76M
Non current deferred liabilities
-4.56%407.22M
-4.56%407.22M
-1.24%410.01M
132.02%413.93M
2,948.00%418.22M
1,602.18%426.67M
1,602.18%426.67M
1,351.39%415.17M
487.53%178.4M
-47.42%13.72M
Other non current liabilities
-39.69%6.21M
-39.69%6.21M
-64.96%3.1M
-66.28%3.16M
-69.39%3.1M
208.04%10.3M
208.04%10.3M
28.55%8.85M
34.73%9.37M
37.77%10.13M
Total non current liabilities
7.93%703.72M
7.93%703.72M
9.76%705.3M
119.03%626.29M
408.27%633.39M
394.96%651.99M
394.96%651.99M
481.28%642.58M
149.52%285.94M
10.35%124.62M
Total liabilities
9.99%918.64M
9.99%918.64M
10.34%902.69M
78.84%795.32M
208.08%806.07M
196.72%835.23M
196.72%835.23M
255.33%818.09M
85.30%444.7M
16.10%261.64M
Shareholders'equity
Share capital
1.67%61K
1.67%61K
1.67%61K
1.67%61K
0.00%60K
1.69%60K
1.69%60K
1.69%60K
1.69%60K
3.45%60K
-common stock
1.67%61K
1.67%61K
1.67%61K
1.67%61K
0.00%60K
1.69%60K
1.69%60K
1.69%60K
1.69%60K
3.45%60K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-27.66%-2.34B
-27.66%-2.34B
-33.13%-2.23B
-35.96%-2.1B
-42.06%-1.96B
-43.71%-1.83B
-43.71%-1.83B
-75.00%-1.67B
-83.58%-1.54B
-88.96%-1.38B
Paid-in capital
4.92%2.47B
4.92%2.47B
4.50%2.43B
4.67%2.41B
4.67%2.38B
4.79%2.36B
4.79%2.36B
5.43%2.33B
5.93%2.3B
6.51%2.28B
Gains losses not affecting retained earnings
66.53%-3.5M
66.53%-3.5M
81.90%-2.68M
70.37%-4.22M
62.00%-4.6M
-152.67%-10.44M
-152.67%-10.44M
-161.34%-14.83M
-144.18%-14.25M
-137.59%-12.11M
Total stockholders'equity
-74.62%130.61M
-74.62%130.61M
-68.36%202.61M
-58.39%311.13M
-53.01%414.3M
-46.98%514.68M
-46.98%514.68M
-48.66%640.31M
-43.73%747.75M
-37.02%881.67M
Total equity
-74.62%130.61M
-74.62%130.61M
-68.36%202.61M
-58.39%311.13M
-53.01%414.3M
-46.98%514.68M
-46.98%514.68M
-48.66%640.31M
-43.73%747.75M
-37.02%881.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -24.80%710.64M-24.80%710.64M-37.29%712.98M-15.29%722.63M40.10%822.16M98.06%944.99M98.06%944.99M61.99%1.14B35.77%853.11M-31.12%586.83M
-Cash and cash equivalents -40.45%71.29M-40.45%71.29M-80.79%55.97M-56.44%75.53M356.26%169.72M-42.98%119.71M-42.98%119.71M-47.36%291.43M-67.55%173.4M-94.67%37.2M
-Short-term investments -22.53%639.36M-22.53%639.36M-22.30%657.01M-4.80%647.11M18.71%652.44M208.90%825.28M208.90%825.28M470.21%845.54M622.85%679.71M256.91%549.63M
Receivables 16.89%43.18M16.89%43.18M88.25%41.25M30.12%38.27M-3.97%31.3M-0.25%36.94M-0.25%36.94M-26.27%21.92M-25.05%29.41M-25.68%32.6M
-Accounts receivable 82.05%42.83M82.05%42.83M111.50%40.86M29.58%35.15M4.34%30.01M-6.48%23.53M-6.48%23.53M5.00%19.32M6.48%27.12M-17.03%28.76M
-Other receivables -97.38%351K-97.38%351K-84.86%393K36.42%3.12M-66.25%1.3M12.95%13.41M12.95%13.41M-77.08%2.6M-83.39%2.29M-58.27%3.84M
Inventory -28.53%21.22M-28.53%21.22M-53.32%16.46M-52.01%17.02M-41.88%17.52M36.12%29.7M36.12%29.7M112.75%35.25M133.08%35.45M88.05%30.15M
Prepaid assets ----------------------------41.63%33.53M60.81%34.2M45.71%37.68M
Other current assets -4.78%33.35M-4.78%33.35M--37.48M--33.42M--29.36M93.89%35.02M93.89%35.02M------------
Total current assets -22.76%808.39M-22.76%808.39M-34.17%808.17M-14.79%811.34M31.01%900.34M88.92%1.05B88.92%1.05B59.06%1.23B35.24%952.18M-26.71%687.24M
Non current assets
Net PPE 0.39%115.65M0.39%115.65M-1.30%115.84M-3.81%114.49M-4.88%113.41M-4.69%115.2M-4.69%115.2M24.61%117.37M23.60%119.02M20.46%119.23M
-Gross PPE 5.23%154.14M5.23%154.14M-1.30%115.84M-3.81%114.49M-4.88%113.41M0.14%146.48M0.14%146.48M24.61%117.37M-0.14%119.02M-0.87%119.23M
-Accumulated depreciation -23.05%-38.49M-23.05%-38.49M-------------23.07%-31.28M-23.07%-31.28M------------
Investments and advances -47.72%84.32M-47.72%84.32M70.17%142.03M50.69%141.72M-45.54%166.94M-71.07%161.27M-71.07%161.27M-85.90%83.46M-87.49%94.05M-46.98%306.53M
Other non current assets 52.66%40.89M52.66%40.89M31.33%39.26M43.03%38.9M30.91%39.68M35.21%26.78M35.21%26.78M54.37%29.89M62.59%27.2M187.81%30.31M
Total non current assets -20.58%240.86M-20.58%240.86M28.78%297.13M22.83%295.11M-29.83%320.03M-56.57%303.25M-56.57%303.25M-67.29%230.73M-72.21%240.27M-33.68%456.06M
Total assets -22.27%1.05B-22.27%1.05B-24.21%1.11B-7.21%1.11B6.74%1.22B7.80%1.35B7.80%1.35B-1.28%1.46B-23.99%1.19B-29.66%1.14B
Liabilities
Current liabilities
Payables 72.59%4.71M72.59%4.71M64.49%6.96M-53.64%6.98M-41.19%10.56M-67.25%2.73M-67.25%2.73M-55.67%4.23M715.00%15.05M521.70%17.96M
-accounts payable 72.59%4.71M72.59%4.71M64.49%6.96M-53.64%6.98M-41.19%10.56M-67.25%2.73M-67.25%2.73M-55.67%4.23M715.00%15.05M521.70%17.96M
Current accrued expenses -26.54%67.09M-26.54%67.09M-32.68%59.82M-34.07%61.43M-2.81%79.69M2.93%91.33M2.93%91.33M28.27%88.86M5.47%93.17M11.55%81.99M
Current provisions 93.07%17.47M93.07%17.47M152.37%16.1M120.37%13.56M136.22%12.03M130.41%9.05M130.41%9.05M117.08%6.38M184.37%6.15M208.91%5.09M
Current debt and capital lease obligation 53.89%42.21M53.89%42.21M64.68%41.84M208.95%29.15M222.63%28.27M238.93%27.43M238.93%27.43M188.38%25.41M11.46%9.44M6.94%8.76M
-Current debt 79.68%30.28M79.68%30.28M97.65%30.22M--17.86M--17.38M--16.85M--16.85M--15.29M--------
-Current capital lease obligation 12.80%11.93M12.80%11.93M14.84%11.62M19.68%11.29M24.25%10.89M30.72%10.58M30.72%10.58M14.82%10.12M11.46%9.44M6.94%8.76M
Current deferred liabilities 82.26%40.01M82.26%40.01M51.93%38.15M111.73%31.74M161.53%25.12M90.72%21.95M90.72%21.95M269.67%25.11M89.46%14.99M-35.44%9.6M
Current liabilities 17.29%214.92M17.29%214.92M12.46%197.38M6.47%169.03M26.02%172.68M22.35%183.23M22.35%183.23M46.64%175.51M26.61%158.76M21.87%137.03M
Non current liabilities
Long term debt and capital lease obligation 35.00%290.29M35.00%290.29M33.69%292.19M113.12%209.2M110.47%212.07M108.12%215.02M108.12%215.02M191.20%218.56M27.03%98.16M26.78%100.76M
-Long term debt 70.61%208.54M70.61%208.54M69.15%208.16M--122.15M--122.13M--122.23M--122.23M--123.06M--------
-Long term capital lease obligation -11.90%81.75M-11.90%81.75M-12.00%84.04M-11.32%87.05M-10.74%89.94M-10.19%92.79M-10.19%92.79M27.24%95.5M27.03%98.16M26.78%100.76M
Non current deferred liabilities -4.56%407.22M-4.56%407.22M-1.24%410.01M132.02%413.93M2,948.00%418.22M1,602.18%426.67M1,602.18%426.67M1,351.39%415.17M487.53%178.4M-47.42%13.72M
Other non current liabilities -39.69%6.21M-39.69%6.21M-64.96%3.1M-66.28%3.16M-69.39%3.1M208.04%10.3M208.04%10.3M28.55%8.85M34.73%9.37M37.77%10.13M
Total non current liabilities 7.93%703.72M7.93%703.72M9.76%705.3M119.03%626.29M408.27%633.39M394.96%651.99M394.96%651.99M481.28%642.58M149.52%285.94M10.35%124.62M
Total liabilities 9.99%918.64M9.99%918.64M10.34%902.69M78.84%795.32M208.08%806.07M196.72%835.23M196.72%835.23M255.33%818.09M85.30%444.7M16.10%261.64M
Shareholders'equity
Share capital 1.67%61K1.67%61K1.67%61K1.67%61K0.00%60K1.69%60K1.69%60K1.69%60K1.69%60K3.45%60K
-common stock 1.67%61K1.67%61K1.67%61K1.67%61K0.00%60K1.69%60K1.69%60K1.69%60K1.69%60K3.45%60K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -27.66%-2.34B-27.66%-2.34B-33.13%-2.23B-35.96%-2.1B-42.06%-1.96B-43.71%-1.83B-43.71%-1.83B-75.00%-1.67B-83.58%-1.54B-88.96%-1.38B
Paid-in capital 4.92%2.47B4.92%2.47B4.50%2.43B4.67%2.41B4.67%2.38B4.79%2.36B4.79%2.36B5.43%2.33B5.93%2.3B6.51%2.28B
Gains losses not affecting retained earnings 66.53%-3.5M66.53%-3.5M81.90%-2.68M70.37%-4.22M62.00%-4.6M-152.67%-10.44M-152.67%-10.44M-161.34%-14.83M-144.18%-14.25M-137.59%-12.11M
Total stockholders'equity -74.62%130.61M-74.62%130.61M-68.36%202.61M-58.39%311.13M-53.01%414.3M-46.98%514.68M-46.98%514.68M-48.66%640.31M-43.73%747.75M-37.02%881.67M
Total equity -74.62%130.61M-74.62%130.61M-68.36%202.61M-58.39%311.13M-53.01%414.3M-46.98%514.68M-46.98%514.68M-48.66%640.31M-43.73%747.75M-37.02%881.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.03%